Attention-deficit/hyperactivity disorder
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Machine scores (provisional)
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
- Teacher spread
- 0.341 · how far apart the two teachers sit on this one work
- Validation status
score_only:v0-immature-baseline· verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is a persistent neurodevelopmental disorder that affects 5% of children and adolescents and 2.5% of adults worldwide. Throughout an individual's lifetime, ADHD can increase the risk of other psychiatric disorders, educational and occupational failure, accidents, criminality, social disability and addictions. No single risk factor is necessary or sufficient to cause ADHD. In most cases ADHD arises from several genetic and environmental risk factors that each have a small individual effect and act together to increase susceptibility. The multifactorial causation of ADHD is consistent with the heterogeneity of the disorder, which is shown by its extensive psychiatric co-morbidity, its multiple domains of neurocognitive impairment and the wide range of structural and functional brain anomalies associated with it. The diagnosis of ADHD is reliable and valid when evaluated with standard criteria for psychiatric disorders. Rating scales and clinical interviews facilitate diagnosis and aid screening. The expression of symptoms varies as a function of patient developmental stage and social and academic contexts. Although there are no curative treatments for ADHD, evidenced-based treatments can markedly reduce its symptoms and associated impairments. For example, medications are efficacious and normally well tolerated, and various non-pharmacological approaches are also valuable. Ongoing clinical and neurobiological research holds the promise of advancing diagnostic and therapeutic approaches to ADHD. For an illustrated summary of this Primer, visit: http://go.nature.com/J6jiwl Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder that affects children and adults. In this Primer, Faraone and colleagues argue that improved understanding of the heterogeneous genetic and environmental mechanisms underlying ADHD is required to improve diagnosis and treatment.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
The record
- Venue
- Nature Reviews Disease Primers
- Topic
- Attention Deficit Hyperactivity Disorder
- Field
- Medicine
- Canadian institutions
- University of TorontoHospital for Sick ChildrenSickKids Foundation
- Funders
- National Institute of Biomedical Imaging and BioengineeringNational Institute of Mental HealthProgramme Grants for Applied ResearchMedical Research CouncilCanadian Institutes of Health ResearchInstitute of Education SciencesNederlandse Organisatie voor Wetenschappelijk OnderzoekNational Institutes of HealthShireNational Institute for Health and Care ResearchUniversitetet i BergenGeneralitat de CatalunyaPlan Nacional sobre DrogasEconomic and Social Research CouncilEuropean CommissionConselho Nacional de Desenvolvimento Científico e TecnológicoInstituto de Salud Carlos IIIZonMw
- Keywords
- NeurocognitiveAttention deficit hyperactivity disorderPsychiatryNeurodevelopmental disorderPsychologyClinical psychologyAddictionMedicineCognitionAutism
- Has abstract in OpenAlex
- yes